Utility Patent

District Courts, Utility Patent

Collision Communications v. Samsung — Judge Denies Injunction Despite $445M Verdict, Even as DOJ Backs NPE’s Irreparable Harm Claim

In a closely watched case, Judge Gilstrap denied a permanent injunction against Samsung despite a $445.5 million willful infringement verdict, finding that the non-practicing patent owner failed to show the balance of hardships favored relief — even though the court accepted its irreparable harm argument, supported by an unusual joint DOJ-USPTO Statement of Interest.

Other International, Utility Patent

Philips v. Rajesh Bansal — Delhi High Court Sets Aside SEP Damages, Holds DVD Patent Not Proven Essential and Imports Exhausted Under Indian Law

The Delhi High Court Division Bench reversed a single judge’s infringement and damages decree against DVD importers, holding that Philips failed to prove its DVD decoding patent was essential to the standard and that the defendants’ imports from licensed manufacturers triggered patent exhaustion under Section 107A(b) of the Indian Patents Act.

Federal Circuit, Utility Patent

Actelion Pharmaceuticals v. Mylan Pharmaceuticals — Federal Circuit Affirms That pH Claims Require Standard-Temperature Measurement

The Federal Circuit affirmed that Actelion’s patent claims requiring a bulk solution with ‘a pH of 13 or higher’ refer to pH measured at standard temperature (25±2°C), not at the solution’s actual operating temperature, finding no literal or equivalent infringement by Mylan’s generic epoprostenol drug.

Federal Circuit, Utility Patent

Seoul Semiconductor v. Finelite — Federal Circuit Affirms Samsung’s Limited Indemnification in LED Patent Dispute

The Federal Circuit affirmed that Samsung’s 2012 sales agreement with Finelite unambiguously incorporated a full contract of sale that limited Samsung’s indemnification obligations to Hong Kong — where title to LED chips passed — leaving Finelite without indemnity coverage for U.S. patent infringement claims brought by Seoul Semiconductor.

Federal Circuit, Utility Patent

Universal Electronics v. Roku — Federal Circuit Affirms PTAB Finding That Remote Control Patent Claims Are Obvious

The Federal Circuit affirmed the PTAB’s finding that claims of Universal Electronics’ remote control codeset patent (U.S. Patent No. 9,847,083) are unpatentable as obvious, agreeing with the Board’s broad construction of ‘protocol and formatting information’ as ‘information needed to transmit a signal from one device to another in a way that the receiving device can make sense of and use the signal.’

Federal Circuit, International Trade Commission, Utility Patent

BISSELL v. ITC — Federal Circuit Affirms That Redesigned Tineco Vacuums Do Not Infringe, Clarifies Expert Reliance on Discovery Source Code

The Federal Circuit affirmed the ITC’s finding that Tineco’s redesigned wet-dry vacuum cleaners do not infringe BISSELL’s patents, while also establishing that ITC experts may rely on source code produced in discovery but never formally admitted as a hearing exhibit under FRE 703.

International Trade Commission, Utility Patent

Infineon v. Innoscience — ITC Import Ban on GaN Chips Takes Effect, But Only for Discontinued Products

The U.S. ITC’s limited exclusion order against Innoscience’s GaN power devices became effective July 7, 2026 after the Presidential Review Period expired, but the ruling’s practical impact is narrow: only two claims of Infineon’s ‘481 patent were found infringed, and only by Innoscience’s already-discontinued legacy products.

District Courts, Utility Patent

Maquet v. Abiomed — Court Issues Three Pre-Trial Rulings on Blood Pump Patent, Preserves Written Description Challenge but Strikes Indefiniteness and Means-Plus-Function Arguments

In three pre-trial rulings, the District of Massachusetts denied summary judgment on Abiomed’s written description defense, eliminated its indefiniteness arguments, declined to kill the reverse doctrine of equivalents, and found waiver on a last-minute means-plus-function claim construction bid — setting the stage for trial on Maquet’s intravascular blood pump patent.

EU Courts, Utility Patent

Gilead Sciences v. Academy of Military Medical Sciences — UPC Revokes Chinese Military Institute’s Remdesivir COVID-19 Patent for Lack of Inventive Step

The UPC Central Division in Milan revoked the Academy of Military Medical Sciences’ European patent on the use of remdesivir to treat COVID-19, finding the claimed invention lacked inventive step because prior art published just ten days before the priority date already identified remdesivir as likely effective against the newly emerged Wuhan coronavirus.

Scroll to Top